profit from every €100 of sales.
€0€100
Equasens Société anonyme
€27.75-0.18% today
-36.6% since Dec 18, 25
1-year low €26.751-year high €45.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2025.
0%20% a year
You pay €10.60 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Equasens Société anonyme sold, what it kept, and what it did with the cash.
Sales went from €193 million in 2021 to €237 million in 2025, with €39.3 million of profit last year.
SalesProfit
Equasens Société anonyme handed back 52% of the cash it generated last year.
€19M
Free cash flow 2025€47M
Bought back its own shares€6M
Paid as dividends€19M
Cash vs. debt€34M vs. €61M
Equasens Société anonyme vs. similar companies
Equasens Société anonyme grows the slowest of these 5 and is the cheapest for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Equasens Société anonyme | 10.6× · Cheap | ||
 Veeva Systems | 54.6× · Expensive | ||
 Pro Medicus | 186.3× · Very expensive | ||
 Hinge Health | No profit yet | ||
 M3 | 31.8× · Expensive |
AI analysis
An AI analyst reads Equasens Société anonyme's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|
| 193 | 214 | 220 | 237 | |
| 134 | 146 | 151 | 163 | |
| 50 | 56 | 56 | 48 | |
| – | 69 | 72 | 71 | |
| 39 | 46 | 47 | 39 | |
| – | 3.06 | 3.13 | 2.73 | |
| 69.3% | 68.0% | 68.5% | 68.7% | |
| 26.0% | 26.3% | 25.4% | 20.2% | |
| 20.3% | 21.7% | 21.4% | 16.6% |
Balance sheet
| In millions of EUR | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|
| Total assets | 330 | 351 | 394 | 439 |
| Cash | 35 | 23 | 18 | 34 |
| Total debt | – | 67 | 66 | 61 |
| Total liabilities | 165 | 154 | 166 | 176 |
| – | – | – | 252 | |
| – | 15 | 15 | 15 | |
| – | – | – | 12.6% | |
| – | – | – | 15.6% |
Cash flow
| In millions of EUR | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|
| – | 57 | 58 | 59 | |
| 10 | 10 | 15 | 12 | |
| – | 47 | 43 | 47 | |
| Dividends paid | 14 | 16 | 17 | 19 |
| 5 | 7 | 5 | 6 | |
| – | 0 | 0 | 0 |
Valuation
- 10.6×
- –
- –
- 2.3×
- 1.8×
- 8.8×
- 6.3×
- 11.3%
- 9.4%
- 4.5%
Profitability
- 68.7%
- 20.2%
- 16.6%
- –
- 12.6%
- 12.6%
- –
- –
- –
- –
Growth
- +5.2%
- –
- –
- –
- −0.3%
Financial health
- 0.4×
- 0.24
- –
- 48.2×
- 1.44
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 20%of 948
Top 23%of 871
Top 11%of 560
Bottom 28%of 868
Top 5%of 985
4.5%of the share price, paid each year
On $1,000 invested$45a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
47.8% of its profit
Room to growStretchedMore than it earns: 39.8%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
5/7Passes 5 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
80Pass
Benjamin Graham
68Pass
Philip Fisher
63Pass
Peter Lynch
60Pass
Joel Greenblatt
54No pass
Charlie Munger
65Pass
Terry Smith
58No pass
Questions about Equasens Société anonyme
Is Equasens Société anonyme a good stock to buy?
A solid business, and the price looks low. 5 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Equasens Société anonyme AI analysis
What does Equasens Société anonyme do?
Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It is in Health Information Services, based in Villers-lès-Nancy, France, with 1,400 employees.
Does Equasens Société anonyme pay a dividend?
Yes. At today's price the dividend is 4.5% a year, about 48% of its yearly profit. In 2025 it paid out €18.8 million in dividends.
Is Equasens Société anonyme stock halal?
Yes. Equasens Société anonyme passes our halal screen: its business is permitted and its debt is 15% of its market value, under the 30% limit. How we check
Who are Equasens Société anonyme's competitors?
The largest listed companies in the same industry are Veeva Systems, Pro Medicus, Hinge Health and M3. The peers table on this page compares their profit, growth and price with Equasens Société anonyme's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.